Barely Significant
← all phrases

“showed a trend”

53,323 sentences · 53,323 papers · 65,371 search hits before verification

In the literature

The most recent subcohort index dates showed a trend for decreasing time to intensification, although there was a slight increase between the cohorts 1 January 2006 to 31 December 2008 and 1 January 2009 to 30 June 2011 (Figure 2 B); i.e. 46.9 and 43.1% of patients whose treatment was intensified were intensified with bolus or premix insulin, respectively, and 10.0% of individuals were intensified with GLP‐1 RAs (data not shown).
There was a lower risk of definite/probable stent thrombosis with long term DAPT among patients with (0.26, 0.09 to 0.80; P=0.02) than without (1.42, 0.68 to 2.98; P=0.35) diabetes, with positive interaction testing (P=0.04 for interaction), although the landmark analysis showed a trend towards benefit in both groups.
Within U-CLL, EZH2 high cases showed a trend for shorter TTFT compared to EZH2 low cases, though not reaching statistical significance (EZH2 high median TTFT = 1.7, EZH2 low median TTFT = 3.3 years, p = 0.14), likely due to the low number of U-CLL EZH2 low cases ( n = 18) ( Supplementary Figure 8 ) DISCUSSION We recently showed that EZH2 is overexpressed in stereotyped CLL subset #1, a paradigmatic aggressive stereotyped subset of CLL cases displaying a distinctive immune signalling profile.
50) One recent study with 157 patients showed a trend that the majority of patients had Class II and Class III indications for ICD implantation. 48) Although the ICD implantation frequency was highest among LQT3 patients, the greatest "save" rate occurred among LQT2 women, who were assessed to be at high risk. 50) The largest study on ICD (n=233, mean
Management of Patients with Long QT Syndrome.
Korean Circ J · 2016 · PMC5099327
2 , 6 , 9 , 10 , 23 In a recent prospective, randomized phase II study comparing cTACE with DEBDOX TACE, the DEBDOX TACE group showed a trend for a higher objective response rate than the cTACE group (51.6% versus 43.5%, respectively), together with better tolerability. 8 , 24 In another prospective, randomized study, DEBDOX TACE resulted in a better objective response than bland embolization with non-loaded bead (73.1% versus 55.9%, res
At 6 months and 1 year follow-up, there was no statistically significant difference among groups regarding freedom from pulsed-steroid therapy, biopsy-confirmed rejection and infection requiring hospitalization, although group A showed a trend toward better freedom from pulsed-steroid therapy and biopsy-confirmed rejection than the other 2 groups ( Table 5; Table S1, SDC, http://links.lww.com/TP/B222 ).